Identification of a novel germ-line mutation in the TP53 gene in a Mexican family with Li-Fraumeni syndrome


Por: Taja-Chayeb L., Vidal-Millán S., Gutiérrez-Hernández O., Trejo-Becerril C., Pérez-Cárdenas E., Chávez-Blanco A., de la Cruz-Hernández E., Duenas-Gonzalez, A

Publicada: 17 dic 2009
Resumen:
Background: Germ-line mutations of the TP53 gene are known to cause Li-Fraumeni syndrome, an autosomal, dominantly inherited, high-penetrance cancer-predisposition syndrome characterized by the occurrence of a variety of cancers, mainly soft tissue sarcomas, adrenocortical carcinoma, leukemia, breast cancer, and brain tumors. Methods: Mutation analysis was based on Denaturing high performance liquid chromatography (DHPLC) screening of exons 2-11 of the TP53 gene, sequencing, and cloning of DNA obtained from peripheral blood lymphocytes. Results: We report herein on Li Fraumeni syndrome in a family whose members are carriers of a novel TP53 gene mutation at exon 4. The mutation comprises an insertion/duplication of seven nucleotides affecting codon 110 and generating a new nucleotide sequence and a premature stop codon at position 150. With this mutation, the p53 protein that should be translated lacks the majority of the DNA binding domain. Conclusion: To our knowledge, this specific a

Filiaciones:
Taja-Chayeb L.:
 Instituto Nacional de Cancerología (INCan), Mexico City, Mexico

Vidal-Millán S.:
 Instituto Nacional de Cancerología (INCan), Mexico City, Mexico

Gutiérrez-Hernández O.:
 Instituto Nacional de Cancerología (INCan), Mexico City, Mexico

Trejo-Becerril C.:
 Instituto Nacional de Cancerología (INCan), Mexico City, Mexico

Pérez-Cárdenas E.:
 Instituto Nacional de Cancerología (INCan), Mexico City, Mexico

Chávez-Blanco A.:
 Instituto Nacional de Cancerología (INCan), Mexico City, Mexico

de la Cruz-Hernández E.:
 Instituto Nacional de Cancerología (INCan), Mexico City, Mexico

Duenas-Gonzalez, A:
 Univ Nacl Autonoma Mexico, IIB, Unidad Invest Biomed Canc, Mexico City 04510, DF, Mexico
ISSN: 14777819
Editorial
BIOMED CENTRAL LTD, CURRENT SCIENCE GROUP, MIDDLESEX HOUSE, 34-42 CLEVELAND ST, LONDON W1T 4LB, ENGLAND, Reino Unido
Tipo de documento: Article
Volumen: 7 Número:
Páginas:
WOS Id: 000273817500001
ID de PubMed: 20017945
imagen Gold